Rapid Dose Therapeutics Corp. reported earnings results for the third quarter and nine months ended November 30, 2023. For the third quarter, the company reported sales was CAD 0.233814 million compared to CAD 0.305629 million a year ago. Net loss was CAD 0.981078 million compared to CAD 0.583504 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.006 a year ago.
For the nine months, sales was CAD 0.827772 million compared to CAD 0.500949 million a year ago. Net loss was CAD 2.25 million compared to CAD 2.51 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.024 a year ago.